The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
Alison M. Paterson, Keturah E. Brown, Mary E Keir et al. · The Journal of Immunology · 2011
Programmed death-1 ligand 1 (PD-L1) is a coinhibitory molecule that negatively regulates multiple tolerance checkpoints. In the NOD mouse model, PD-L1 regulates the development of diabetes. PD-L1 has two binding partners, programmed death-1 and B7-1, but the significance of the PD-L1:B7-1 interaction in regulating self-reactive T cell responses is not yet clear. To investigate this issue in NOD mice, we have compared the effects of two anti-PD-L1 Abs that have different blocking activities. Anti-PD-L1 mAb 10F.2H11 sterically and functionally blocks only PD-L1:B7-1 interactions, whereas anti-PD-L1 mAb 10F.9G2 blocks both PD-L1:B7-1 and PD-L1:programmed death-1 interactions. Both Abs had potent, yet distinct effects in accelerating diabetes in NOD mice: the single-blocker 10F.2H11 mAb was more effective at precipitating diabetes in older (13-wk-old) than in younger (6- to 7-wk-old) mice, whereas the dual-blocker 10F.9G2 mAb rapidly induced diabetes in NOD mice of both ages. Similarly, 10F.2H11 accelerated diabetes in recipients of T cells from diabetic, but not prediabetic mice, whereas 10F.9G2 was effective in both settings. Both anti-PD-L1 mAbs precipitated diabetes in adoptive transfer models of CD4(+) and CD8(+) T cell-driven diabetes. Taken together, these data demonstrate that the PD-L1:B7-1 pathway inhibits potentially pathogenic self-reactive effector CD4(+) and CD8(+) T cell responses in vivo, and suggest that the immunoinhibitory functions of this pathway may be particularly important during the later phases of diabetogenesis.
Cited by 202 works. doi:10.4049/jimmunol.1003496 Open-access PDF
Authors
- Alison M. Paterson
- Keturah E. Brown
- Mary E Keir
- Vijay K. Vanguri
- Leonardo V. Riella
- Anil K. Chandraker
- Mohamed H. Sayegh
- Bruce R. Blazar
- Gordon James Freeman
- Arlene H. Sharpe
References
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
- B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
- PD-1 and Its Ligands in Tolerance and Immunity
- PD-L2 is a second ligand for PD-1 and inhibits T cell activation
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses
- B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
- Inhibitory B7-family molecules in the tumour microenvironment
- The PD‐1 pathway in tolerance and autoimmunity
- Tissue expression of PD-L1 mediates peripheral T cell tolerance
- Expression of Programmed Death 1 Ligands by Murine T Cells and APC